Vijay Vaswani at ARDD2025: Decoding the Immune System for Healthspan: osLifetime, a Cellular Age ...

Vijay Vaswani at ARDD2025: Decoding the Immune System for Healthspan: osLifetime, a Cellular Age ...

🎙 Vijay Vaswani 👥 9K 📅 February 13, 2026 ⏱ 19 min 👁 304 📄 original study 🧭 2026-08-16
Available in: English (current) Français

Keywords

immune ageinflammagingT cellssenescencepersonalized health

Summary

Vijay Vaswani, founder of Omniscope, presents at ARDD2025 a platform called osLifetime that decodes the immune system at single-cell resolution to assess biological age and guide personalized health interventions. He emphasizes that the immune system is a key driver of aging and age-related diseases, and that understanding it cell-by-cell is crucial. The talk covers the technology’s ability to analyze over a million cells per sample, its application in matching patients to existing therapies, and its role in engineering immune cells for cancer treatment. Vaswani shares his personal n-of-1 experiment, where he used the platform to identify his own immune age, high inflammation, and psoriasis, and then implemented lifestyle changes (diet, sleep, exercise) that reduced his inflammation and improved his health metrics. He also discusses collaborations with FC Barcelona to study elite athletes, revealing that immune age is elastic and responds to physical exertion. The talk concludes with a call for practical geroscience and the availability of the platform for drug development and clinical use.

164 words

Critical Evaluation

Value of the Information & Strength of the Argument

The talk provides valuable insights into the application of single-cell immune profiling for aging research and personalized health. The argumentation is persuasive, leveraging the speaker’s personal experience and company data. However, the scientific evidence is largely anecdotal (n-of-1) and lacks rigorous peer-reviewed validation. The claims about the platform’s capabilities are impressive but not fully substantiated in the talk.

Scientific Rigor, Source Quality, Title Accuracy

The talk references several sources, including the Annals of Oncology publication and the World Vaccine Congress presentation, but does not provide specific citations or URLs. The title accurately reflects the content. The scientific rigor is moderate; the speaker mentions peer-reviewed science and collaborations with institutions like UCSF, but the lack of detailed methodology and independent verification limits the overall reliability.

133 words

Title / Content Match

The title accurately reflects the content, focusing on decoding the immune system for healthspan and introducing the osLifetime model.

Quality & Reliability

6/10

The talk presents original data from the company's proprietary platform, but lacks detailed methodology and independent validation. Claims are plausible but not fully verifiable from the talk alone.

Key Moments

Cited Sources

  • Annals of Oncology publication on engineering T cells — Mentioned as published work on engineering T cells using mRNA for cancer treatment.
  • World Vaccine Congress presentation — Mentioned as a presentation on understanding immune response to Shingrix vaccination.

Concurring Sources

  • Hallmarks of aging — The talk aligns with the established hallmarks of aging, particularly those related to the immune system.
  • Single-cell RNA sequencing — The technology described is based on single-cell analysis, which is a recognized field.

Dissenting Sources

  • N-of-1 studies — The talk's reliance on a single individual's data is not generalizable, and the scientific community often requires larger cohorts for validation.

Contribution & Novelties

The talk introduces osLifetime, a platform that provides a comprehensive cellular age model based on immune system analysis, offering a new axis for understanding aging beyond genetics. It emphasizes the practical application of immune profiling for personalized health interventions and highlights the elasticity of immune age in response to lifestyle and exercise. The n-of-1 approach, while not scientifically rigorous, demonstrates the potential for self-quantification and democratization of health data.

Pour aller plus loin :

114 words

Radar Profile

The radar profile shows high scores in quantity and technical level, reflecting the depth of information and specialized content. However, the quality and reliability scores are moderate, indicating that while the information is presented with authority, it lacks rigorous scientific validation.

Reliability 6/10

💬 No comments were provided for analysis.